A medicine made from the marijuana plant moved one step closer to U.S. approval Thursday after federal health advisers endorsed it for the treatment of severe seizures in children with epilepsy.
If the Food and Drug Administration follows the group's recommendation, GW Pharmaceuticals' syrup would become the first drug derived from the cannabis plant to win federal approval in the U.S.
More >> US experts back marijuana-based drug for childhood seizures
